- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Ulf H. Grundmann
News 26 results
Recognition
Mai 17, 2024
LMG Life Sciences EMEA Names Ulf Grundmann its Parallel Import Lawyer of the Year
Recognition
März 27, 2024
Legal 500 EMEA 2024 Ranks King & Spalding among the Top Firms in Europe, the Middle East and Africa
Recognition
Februar 19, 2024
Legal 500 Deutschland 2024 Ranks King & Spalding Among Germany’s Leading Law Firms
Recognition
November 15, 2023
King & Spalding Once Again Receives Novartis’ “Excellence in Litigation” Award
Events 36 results
Speaking Engagement
März 15, 2024
Ulf Grundmann to Speak at 27th Marburg Discussions
Webinar
Februar 15, 2024
The Rise of Government Regulation of Digital Health and Artificial Intelligence/Machine Learning
Speaking Engagement
Dezember 1, 2023
Ulf Grundmann to Speak at Frankfurt School of Finance and Management’s International Healthcare Management MBA Program
Conference
November 7, 2023
Pharmaceutical University 2023
Insights 16 results
Client Alert
Juli 22, 2024
EU Artificial Intelligence Regulation Published - What You Need to Know
Feature
Dezember 8, 2023
General Counsel’s Decision Tree for Internal Investigations for the Food and Beverage Industry
Client Alert
Juni 22, 2023
EU Aims for Ban of PFAS. Now is the Time to Act.